Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Aevi Genomic Medicine Inc (NASDAQ:GNMX)

1.63
Delayed Data
As of Apr 27
 +0.09 / +5.84%
Today’s Change
1.30
Today|||52-Week Range
6.89
-68.53%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Year
Trend

2013

2014

2015

2016
Revenue and IncomeNet Revenues0.000.000.000.00--
Depreciation And Amortization177.0K225.0K240.0K268.0K
 
 
 
 
 
 
Operating ExpensesGross Income-177.0K-225.0K-240.0K-268.0K
 
 
 
 
 
General Expenses17.5M18.7M28.2M40.4M
 
 
 
 
 
Research And Development7.3M8.3M15.4M28.4M
 
 
 
 
 
Total Operating Expenses17.6M18.9M28.4M40.7M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income-17.6M-18.9M-28.4M-40.7M
 
 
 
 
 
Extraordinary Credit720.0K585.0K0.000.00
 
 
 
Extraordinary Charge-186.0K---9.5M-1.2M
 
 
 
 
Interest Expense On Debt0.0020.0K20.0K15.0K
 
 
 
 
Other Expenses-17.0K-48.0K-18.0K-4.0K
 
 
 
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income-17.1M-18.4M-38.0M-41.9M
 
 
 
 
 
Income Taxes-17.0K-12.0K-17.0K-16.0K
 
 
 
 
 
Net Income-17.1M-18.4M-38.0M-41.9M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS17.6M19.2M26.8M35.2M
 
 
 
 
 
Shares To Calculate EPS Diluted17.7M19.3M26.8M35.2M
 
 
 
 
 
 
Earnings Per ShareEPS-$1.06-$1.00-$1.45-$1.19
 
 
 
 
 
EPS Diluted-$1.06-$1.00-$1.45-$1.19